Delivery Order SPE2DR25D1106-SPE2DR26FJA4G
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,733.24 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60GM) on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price contract represents a non-set-aside competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,807.26 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in 60-gram units. This firm fixed-price contract, issued on October 31, 2025, with completion by November 3, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order valued at $76,019.41 to AmerisourceBergen Drug Corp for Opzelura 1.5% cream (60gm) on October 22, 2025, with an ultimate completion date of October 23, 2025. This firm fixed price, non-competitive delivery order represents a specific pharmaceutical requisition fulfilled through AmerisourceBergen's existing contract vehicle with DLA. The company, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $3,406.37 to AmerisourceBergen Drug Corp for 60 grams of Opzelura 1.5% cream, a topical pharmaceutical product. This non-set-aside, firm fixed price delivery order was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order represents a...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $12,289.56 by the Defense Logistics Agency (DLA) for the supply of Opzelura 1.5% Cream in 60-gram quantities. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by November 17, 2025. The contract represents pharmaceutical support for federal medical procurement needs, with performance taking place at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Opzelura 1.5% Cream in 60-gram units, with a ceiling value of $3,943.55 and an ultimate completion date of November 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $7,999.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 grams of Opzelura 1.5% cream, with an ultimate completion date of November 17, 2025. This non-competitive, non-set-aside award represents a child delivery order under AmerisourceBergen's substantial indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,277.56 to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is set to be completed by October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 8, 2024, for the supply of Opzelura 1.5% cream in 60-gram units, valued at $22,363.62. This firm fixed price delivery order, with an ultimate completion date of November 12, 2024, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Opzelura 1.5% cream in 60-gram quantities, with a ceiling value of $6,776.02 and an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJA4GDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $43,268.98 to AmerisourceBergen Drug Corp for Opzelura 1.5% cream (60 grams) on November 20, 2025, with completion expected by November 21, 2025. This firm fixed-price, non-set-aside contract is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying pharmaceuticals and medical supplies to support military and veteran healthcare systems. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's comprehensive global pharmaceutical support vehicle with the Defense Logistics Agency. The company's extensive federal contract portfolio demonstrates its capability to fulfill competitively awarded contracts across multiple therapeutic domains, ranging from specialty medications to generic drugs and medical devices. As a major healthcare solutions provider, AmerisourceBergen supplies products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms designed to support military operations and personnel healthcare needs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.3k | 11/20/25 |